CU6 12.1% $7.67 clarity pharmaceuticals ltd

Ann: First patient dosed in Phase III prostate cancer trial, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,718 Posts.
    lightbulb Created with Sketch. 894
    Every announcement is adding value. 2024 could be one that we speak to our grand kids about. And that’s not hyperbole. It may be the year of the biggest % gains and solidifies the years ahead.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.